Peter J. Hudson

9.7k total citations · 3 hit papers
93 papers, 7.7k citations indexed

About

Peter J. Hudson is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Peter J. Hudson has authored 93 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Radiology, Nuclear Medicine and Imaging, 63 papers in Molecular Biology and 19 papers in Oncology. Recurrent topics in Peter J. Hudson's work include Monoclonal and Polyclonal Antibodies Research (64 papers), Glycosylation and Glycoproteins Research (34 papers) and Protein purification and stability (20 papers). Peter J. Hudson is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (64 papers), Glycosylation and Glycoproteins Research (34 papers) and Protein purification and stability (20 papers). Peter J. Hudson collaborates with scholars based in Australia, United States and United Kingdom. Peter J. Hudson's co-authors include Philipp Holliger, Alexander A. Kortt, Christelle Souriau, Hennie R. Hoogenboom, David J. Chiswell, Andrew D. Griffiths, Kevin S. Johnson, Greg Winter, Olan Dolezal and Barbara Power and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Peter J. Hudson

92 papers receiving 7.4k citations

Hit Papers

Engineered antibody fragments and the rise of ... 1987 2026 2000 2013 2005 1987 1991 400 800 1.2k

Peers

Peter J. Hudson
Christoph Rader United States
Brian K. Kay United States
Herren Wu United States
Sherie L. Morrison United States
Jennifer R. Cochran United States
Robert F. Kelley United States
Peter J. Hudson
Citations per year, relative to Peter J. Hudson Peter J. Hudson (= 1×) peers Roland E. Kontermann

Countries citing papers authored by Peter J. Hudson

Since Specialization
Citations

This map shows the geographic impact of Peter J. Hudson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Hudson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Hudson more than expected).

Fields of papers citing papers by Peter J. Hudson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. Hudson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Hudson. The network helps show where Peter J. Hudson may publish in the future.

Co-authorship network of co-authors of Peter J. Hudson

This figure shows the co-authorship network connecting the top 25 collaborators of Peter J. Hudson. A scholar is included among the top collaborators of Peter J. Hudson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter J. Hudson. Peter J. Hudson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Onzen, Arthur H. A. M. van, Ron M. Versteegen, Freek J. M. Hoeben, et al.. (2020). Bioorthogonal Tetrazine Carbamate Cleavage by Highly Reactive trans -Cyclooctene. Journal of the American Chemical Society. 142(25). 10955–10963. 86 indexed citations
2.
Duijnhoven, Sander M. J. van, Raffaella Rossin, Sandra M. van den Bosch, et al.. (2015). Diabody Pretargeting with Click Chemistry In Vivo. Journal of Nuclear Medicine. 56(9). 1422–1428. 67 indexed citations
3.
Kelly, Marcus P., Barbara Power, Fiona E. Smyth, et al.. (2008). Tumor Targeting by a Multivalent Single-Chain Fv (scFv) Anti-Lewis Y Antibody Construct. Cancer Biotherapy and Radiopharmaceuticals. 23(4). 411–424. 32 indexed citations
4.
Rothe, Achim, Barbara Power, & Peter J. Hudson. (2008). Therapeutic advances in rheumatology with the use of recombinant proteins. Nature Clinical Practice Rheumatology. 4(11). 605–614. 10 indexed citations
5.
Robert, R., Olan Dolezal, Lynne J. Waddington, et al.. (2008). Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers. Protein Engineering Design and Selection. 22(3). 199–208. 42 indexed citations
6.
Streltsov, Victor A., Andrew M. Coley, Olan Dolezal, et al.. (2007). Structure of an IgNAR-AMA1 Complex: Targeting a Conserved Hydrophobic Cleft Broadens Malarial Strain Recognition. Structure. 15(11). 1452–1466. 91 indexed citations
7.
Wark, Kim L. & Peter J. Hudson. (2006). Latest technologies for the enhancement of antibody affinity. Advanced Drug Delivery Reviews. 58(5-6). 657–670. 70 indexed citations
8.
Power, Barbara, Alexander A. Kortt, & Peter J. Hudson. (2003). Generation of Recombinant Multimeric Antibody Fragments for Tumor Diagnosis and Therapy. Humana Press eBooks. 207. 335–350. 7 indexed citations
10.
Kortt, Alexander A., et al.. (2002). Large-scale bacterial fermentation and isolation of scFv multimers using a heat-inducible bacterial expression vector. Journal of Immunological Methods. 262(1-2). 217–227. 21 indexed citations
11.
Irving, Robert A., et al.. (2001). Ribosome display and affinity maturation: from antibodies to single V-domains and steps towards cancer therapeutics. Journal of Immunological Methods. 248(1-2). 31–45. 73 indexed citations
12.
Pellicci, Daniel G., Alexander A. Kortt, Lindsay G. Sparrow, et al.. (2000). Expression and purification of antigenically active soluble derivatives of the heterodimeric and homodimeric forms of the mouse CD8 lymphocyte membrane glycoprotein. Journal of Immunological Methods. 246(1-2). 149–163. 3 indexed citations
13.
Nuttall, Stewart D., Mat Rousch, Robert A. Irving, et al.. (1999). Design and expression of soluble CTLA-4 variable domain as a scaffold for the display of functional polypeptides. Proteins Structure Function and Bioinformatics. 36(2). 217–227. 33 indexed citations
14.
Nuttall, Stewart D., Mat Rousch, Robert A. Irving, et al.. (1999). Design and expression of soluble CTLA‐4 variable domain as a scaffold for the display of functional polypeptides. Proteins Structure Function and Bioinformatics. 36(2). 217–227. 1 indexed citations
15.
Dougan, David A., Robyn Malby, LC Gruen, Alexander A. Kortt, & Peter J. Hudson. (1998). Effects of substitutions in the binding surface of an antibody on antigen affinity. Protein Engineering Design and Selection. 11(1). 65–74. 59 indexed citations
16.
Kortt, Alexander A., Myoung Soo Lah, Lesley A. Pearce, et al.. (1997). Single-chain Fv fragments of anti-neuraminidase antibody NC10 containing five- and ten-residue linkers form dimers and with zero- residue linker a trimer. Protein Engineering Design and Selection. 10(4). 423–433. 105 indexed citations
17.
Hoogenboom, Hennie R., Andrew D. Griffiths, Kevin S. Johnson, et al.. (1991). Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. Nucleic Acids Research. 19(15). 4133–4137. 833 indexed citations breakdown →
18.
Suva, Larry J., Karen A. Mather, Matthew T. Gillespie, et al.. (1989). Structure of the 5' flanking region of the gene encoding human parathyroid-hormone-related protein (PTHrP). Gene. 77(1). 95–105. 87 indexed citations
19.
Zajac, Jeffrey D., et al.. (1989). Production of parathyroid hormone-related protein by a rat parathyroid cell line. Molecular and Cellular Endocrinology. 67(1). 107–112. 26 indexed citations
20.
Thomas, Tim, Barbara Power, Peter J. Hudson, Gerhard Schreiber, & Marie Dziadek. (1988). The expression of transthyretin mRNA in the developing rat brain. Developmental Biology. 128(2). 415–427. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026